Literature DB >> 29663562

Atrial fibrillation ablation using cryoballoon technology: Recent advances and practical techniques.

Shaojie Chen1, Boris Schmidt1, Stefano Bordignon1, Fabrizio Bologna1, Laura Perrotta1, Takahiko Nagase1, K R Julian Chun1.   

Abstract

Atrial fibrillation (AF) affects 1-2% of the population, and its prevalence is estimated to double in the next 50 years as the population ages. AF results in impaired patients' life quality, deteriorated cardiac function, and even increased mortality. Antiarrhythmic drugs frequently fail to restore sinus rhythm. Catheter ablation is a valuable treatment approach for AF, even as a first-line therapy strategy in selected patients. Effective electrical pulmonary vein isolation (PVI) is the cornerstone of all AF ablation strategies. Use of radiofrequency (RF) catheter in combination of a three-dimensional electroanatomical mapping system is the most established ablation approach. However, catheter ablation of AF is challenging even sometimes for experienced operators. To facilitate catheter ablation of AF without compromising the durability of the pulmonary vein isolation, "single shot" ablation devices have been developed; of them, cryoballoon ablation, is by far the most widely investigated. In this report, we review the current knowledge of AF and discuss the recent evidence in catheter ablation of AF, particularly cryoballoon ablation. Moreover, we review relevant data from the literature as well as our own experience and summarize the key procedural practical techniques in PVI using cryoballoon technology, aiming to shorten the learning curve of the ablation technique and to contribute further to reduction of the disease burden.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; cryoablation; phrenic nerve damage; rhythm control

Mesh:

Year:  2018        PMID: 29663562     DOI: 10.1111/jce.13607

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

1.  Pulsed field ablation for pulmonary vein isolation: real-world experience and characterization of the antral lesion size compared with cryoballoon ablation.

Authors:  Christian Blockhaus; Jan-Erik Guelker; Ludger Feyen; Alexander Bufe; Melchior Seyfarth; Dong-In Shin
Journal:  J Interv Card Electrophysiol       Date:  2022-08-30       Impact factor: 1.759

2.  Effects of different ablation strategies on long-term left atrial function in patients with paroxysmal atrial fibrillation: a single-blind randomized controlled trial.

Authors:  Ling You; Lixia Yao; Bolun Zhou; Lili Jin; Honglin Yin; Jinglan Wu; Guangli Yin; Ying Yang; Chenfeng Zhang; Yue Liu; Ruiqin Xie
Journal:  Sci Rep       Date:  2019-05-22       Impact factor: 4.379

3.  Transesophageal echocardiography guided transseptal puncture and nadir temperatures in cryoballoon pulmonary vein isolation.

Authors:  Christian Blockhaus; Hans-Peter Waibler; Jan-Erik Guelker; Heinrich Klues; Alexander Bufe; Melchior Seyfarth; Buelent Koektuerk; Dong-In Shin
Journal:  J Arrhythm       Date:  2022-02-04

4.  Comparison of the Efficacy and Safety Endpoints of Five Therapies for Atrial Fibrillation: A Network Meta-Analysis.

Authors:  Tongyu Wang; Tingting Fang; Zeyi Cheng
Journal:  Front Cardiovasc Med       Date:  2022-06-03

5.  Reablation in Atrial Fibrillation Recurrence and Pulmonary Vein Reconnection: Cryoballoon versus Radiofrequency as Index Ablation Procedures.

Authors:  Ana Isabel Molina-Ramos; Amalio Ruiz-Salas; Carmen Medina-Palomo; Francisco Javier Pavón-Morón; Jorge Rodríguez-Capitán; Mario Gutiérrez-Bedmar; Germán Berteli-García; Ignacio Fernández-Lozano; Juan José Gómez-Doblas; Manuel Jiménez-Navarro; Javier Alzueta-Rodríguez; Alberto Barrera-Cordero
Journal:  J Clin Med       Date:  2022-10-03       Impact factor: 4.964

6.  Modified hockey stick maneuver utilizing a steerable cryoballoon catheter for left inferior pulmonary vein isolation.

Authors:  Taihei Itoh; Masaomi Kimura; Hirofumi Tomita
Journal:  J Arrhythm       Date:  2019-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.